HLB Therapeutics Co.,Ltd.

A115450

KR7115450009

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-13 pm EDT			5-day change	1st Jan Change
7,200 ^KRW	-1.23%		-1.91%	+64.20%

May. 16	HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	CI

G-treeBNT Co., Ltd. announced that it has received KRW 8.1000036 billion in funding from Supex BNP Co., Ltd.

September 04, 2018

On September 5, 2018, G-treeBNT Co., Ltd. (KOSDAQ:A115450) closed the transaction.

Latest news about HLB Therapeutics Co.,Ltd.

HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 16	CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	Mar. 31	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
HLB Life Science Co., Ltd. announced that it has received KRW 8.3 billion in funding from HLB Therapeutics Co.,Ltd.	23-07-06	CI
HLB Life Science Co., Ltd. announced that it expects to receive KRW 8.3 billion in funding from HLB Therapeutics Co.,Ltd.	23-06-28	CI
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors	23-06-20	CI
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd.	23-06-20	CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 2.5 billion in funding	23-06-15	CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 5 billion in funding	23-06-15	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
HLB innoVation Co.,Ltd. announced that it has received KRW 55.99999522 billion in funding from a group of investors	23-03-12	CI
Oblato, Inc. announced that it has received KRW 18.408 billion in funding from HLB Therapeutics Co.,Ltd.	23-02-13	CI
Oblato, Inc. announced that it expects to receive KRW 18.408 billion in funding from HLB Therapeutics Co.,Ltd.	23-02-05	CI
HLB innoVation Co.,Ltd. announced that it expects to receive KRW 55.99999522 billion in funding from a group of investors	23-01-31	CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 13.0088 billion in funding from HLB Co., Ltd.	23-01-11	CI
HLB Therapeutics to Raise 13 Billion Won via Stock Sale	23-01-04	MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 13.0088 billion in funding from HLB Co., Ltd.	23-01-03	CI
HLB Therapeutics Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
HLB Therapeutics Submits Phase 3 Protocol for Neurotrophic Keratopathy	22-09-27	CI
HLB Therapeutics Signs Letter of Intent with Global Ophthalmology CRO for Two Phase 3 Clinical Trials in Neurotrophic Keratitis	22-07-18	CI
G-treeBNT Co., Ltd. announced that it has received KRW 95.000054256 billion in funding from a group of investors	21-11-15	CI
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 95.000054256 billion in funding from a group of investors	21-09-12	CI
G-treeBNT Co., Ltd. announced that it has received KRW 10 billion in funding from Shinhan Investment Corp., BFA Co.,Ltd., Bayside Private Equity	21-07-27	CI

Chart HLB Therapeutics Co.,Ltd.

Duration

Period

More charts

HLB Therapeutics Co Ltd, formerly G-treeBNT Co Ltd, is a Korea-based company engaged in the research and development of optimized multimedia software for various digital appliances including cellular phones. Along with its affiliates, the Company operates solution business segment, which provides embedded graphic user interface (GUI) software solutions as well as wired and wireless integration multimedia platform solutions. Its embedded GUI products include FXUI-two-dimensional (2D), FXUI-three-dimensional (3D) and FX Studio, which are used for cellular phones and embedded equipment. Its wired and wireless integration multimedia platform products include FX-Flash and others, which are used for cellular phones and other mobile devices; electronic components manufacturing business segment, which provides transformers, pumps, motors and others, as well as educational and bio pharmaceutical business segments.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
HLB THERAPEUTICS CO.,LTD.	+64.20%	411M
MCKESSON CORPORATION	+27.42%	76.68B
CARDINAL HEALTH, INC.	-0.60%	24.41B
SINOPHARM GROUP CO. LTD.	+7.82%	8.81B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+10.46%	8.48B
HUADONG MEDICINE CO., LTD	-25.33%	7.47B
H. LUNDBECK A/S	+15.02%	5.21B
GALENICA AG	+1.24%	4.12B
EBOS GROUP LIMITED	-8.45%	3.86B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-3.20%	3.56B